Healthcare provider profile · identity verified

Jose S Leon, MD

Internal Medicine · NORTHPORT, NY · NPI 1962494591

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	963	293
Amlodipine Besylate	Amlodipine Besylate	655	180
Metformin Hcl	Metformin Hcl	589	168
Levothyroxine Sodium	Levothyroxine Sodium	499	137
Omeprazole	Omeprazole	390	113
Losartan Potassium	Losartan Potassium	315	97
Fluticasone Propionate	Fluticasone Propionate	269	107
Metoprolol Succinate	Metoprolol Succinate	268	85
Tamsulosin Hcl	Tamsulosin Hcl	245	74
Montelukast Sodium	Montelukast Sodium	228	68
Gabapentin	Gabapentin	227	74
Simvastatin	Simvastatin	216	63
Furosemide	Furosemide	211	57
Pantoprazole Sodium	Pantoprazole Sodium	202	69
Rosuvastatin Calcium	Rosuvastatin Calcium	199	68
Albuterol Sulfate Hfa	Albuterol Sulfate	192	69
Alprazolam	Alprazolam	185	45
Glimepiride	Glimepiride	180	54
Ozempic	Semaglutide	177	43
Zolpidem Tartrate	Zolpidem Tartrate	177	29
Trazodone Hcl	Trazodone Hcl	171	52
Meloxicam	Meloxicam	166	52
Metoprolol Tartrate	Metoprolol Tartrate	155	39
Hydrochlorothiazide	Hydrochlorothiazide	145	46
Carvedilol	Carvedilol	137	40
Clopidogrel	Clopidogrel Bisulfate	132	46
Lisinopril	Lisinopril	132	44
Sertraline Hcl	Sertraline Hcl	122	29
Azelastine Hcl	Azelastine Hcl	120	39
Famotidine	Famotidine	120	37
Pioglitazone Hcl	Pioglitazone Hcl	111	36
Eliquis	Apixaban	109	30
Tizanidine Hcl	Tizanidine Hcl	106	22
Meclizine Hcl	Meclizine Hcl	99	41
Methylprednisolone	Methylprednisolone	99	69
Potassium Chloride	Potassium Chloride	97	30
Naproxen	Naproxen	96	29
Alendronate Sodium	Alendronate Sodium	90	32
Allopurinol	Allopurinol	87	28
Fenofibrate	Fenofibrate Nanocrystallized	85	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	38
Atenolol	Atenolol	80	24
Quetiapine Fumarate	Quetiapine Fumarate	80	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	19
Escitalopram Oxalate	Escitalopram Oxalate	77	18
Valsartan	Valsartan	76	24
Buspirone Hcl	Buspirone Hcl	75	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	23
Duloxetine Hcl	Duloxetine Hcl	73	19
Diclofenac Sodium	Diclofenac Sodium	71	21
Metformin Hcl Er	Metformin Hcl	71	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	70	21
Synthroid	Levothyroxine Sodium	69	20
Triamcinolone Acetonide	Triamcinolone Acetonide	66	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	18
Tramadol Hcl	Tramadol Hcl	62	18
Ibuprofen	Ibuprofen	61	18
Memantine Hcl	Memantine Hcl	61	16
Irbesartan	Irbesartan	60	13
Paroxetine Hcl	Paroxetine Hcl	60	14
Ezetimibe	Ezetimibe	56	20
Spironolactone	Spironolactone	56	19
Enalapril Maleate	Enalapril Maleate	55	19
Tresiba Flextouch U-200	Insulin Degludec	55	16
Amitriptyline Hcl	Amitriptyline Hcl	54	14
Hydralazine Hcl	Hydralazine Hcl	54	18
Pravastatin Sodium	Pravastatin Sodium	54	16
Ramipril	Ramipril	53	16
Finasteride	Finasteride	52	18
Mounjaro	Tirzepatide	52	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	51	14
Nifedipine Er	Nifedipine	50	11
Mirtazapine	Mirtazapine	48	14
Prednisone	Prednisone	48	34
Valacyclovir	Valacyclovir Hcl	47	15
Glipizide	Glipizide	45	12
Januvia	Sitagliptin Phosphate	44	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	44	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	14
Celecoxib	Celecoxib	41	suppressed
Jardiance	Empagliflozin	41	13
Trulicity	Dulaglutide	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	35
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Novolog Flexpen	Insulin Aspart	36	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Levetiracetam	Levetiracetam	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Torsemide	Torsemide	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Farxiga	Dapagliflozin Propanediol	30	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	21
Donepezil Hcl	Donepezil Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	28	13
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Ammonium Lactate	Ammonium Lactate	22	11
Levofloxacin	Levofloxacin	22	20
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Azithromycin	Azithromycin	21	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Cromolyn Sodium	Cromolyn Sodium	20	11
Primidone	Primidone	19	suppressed
Procto-Med Hc	Hydrocortisone	19	suppressed
Testosterone	Testosterone	19	suppressed
Cephalexin	Cephalexin	18	13
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Cartia Xt	Diltiazem Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Risperidone	Risperidone	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	15	suppressed
Hyoscyamine Sulfate	Hyoscyamine Sulfate	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Topiramate	Topiramate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Novolin R Flexpen	Insulin Regular, Human	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Lactulose	Lactulose	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error